Sectors
TENX
Tenax Therapeutics, Inc.
1.84
2 x 1.50
2 x 2.24
bid
ask
-
0.29
13.62%
2 @ 07:59 PM
1.84 +0.00 (0.00%)
| Ytd | -84.91% | |
| 1y | -69.28% |
1.73
day range
2.11
1.31
52 week range
19.40
| Open | 2.08 | Prev Close | 2.13 | Low | 1.73 | High | 2.11 | Mkt Cap | 68.86M |
| Vol | 17.24M | Avg Vol | 4.28M | EPS | -1.48 | P/E | N/A | Forward P/E | -1.06 |
| Beta | 2.15 | Short Ratio | 1.46 | Inst. Own | 47.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 10.91 | 200-d Avg | 12.02 | 1yr Est | 16.30 |
| Income Statement | |||
| Operating Expenses | 18.78M | ||
| Research and Development Expense | 12.85M | ||
| Selling, General and Administrative Expense | 5.93M | ||
| Operating Income | -18.78M | ||
| Net Income | -17.80M | ||
| Net Income Common Stock | -17.80M | ||
| Net Income Common Stock (USD) | -17.80M | ||
| Consolidated Income | -17.80M | ||
| Earnings per Basic Share | -0.35 | ||
| Earnings per Basic Share (USD) | -0.35 | ||
| Earnings per Diluted Share | -0.35 | ||
| Earning Before Interest & Taxes (EBIT) | -17.80M | ||
| Earning Before Interest & Taxes (USD) | -17.80M | ||
| Weighted Average Shares | 50.87M | ||
| Weighted Average Shares Diluted | 50.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 117.98M | ||
| Cash and Equivalents (USD) | 117.98M | ||
| Current Assets | 121.66M | ||
| Total Assets | 121.66M | ||
| Current Liabilities | 8.07M | ||
| Total Liabilities | 8.07M | ||
| Accumulated Retained Earnings (Deficit) | -400.97M | ||
| Shareholders Equity | 113.59M | ||
| Shareholders Equity (USD) | 113.59M | ||
| Trade and Non-Trade Payables | 6.80M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 13.37M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -779.00K | ||
| Issuance (Purchase) of Equity Shares | 13.37M | ||
| Net Cash Flow from Operations | -14.15M | ||
| Share Based Compensation | 3.33M | ||